Admission Date:  [**2162-3-22**]              Discharge Date:   [**2162-3-30**]  Date of Birth:  [**2089-4-6**]             Sex:   M  Service: CARDIOTHORACIC  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1283**] Chief Complaint: Chest pain and dyspnea on exertion  Major Surgical or Invasive Procedure: [**2162-3-22**] - Mitral Valve Replacement(31mm CE Permount Pericardial Bioprosthetic Valve), CABGx1(vein graft to first obtuse marginal), and MAZE Procedure   History of Present Illness: Mr. [**Known lastname 1617**] is a 72 y/o man with a three year history of MR followed by serial echocardiograms at the [**Hospital6 **].
Mr. [**Known lastname 1617**] was seen in clinic and now presents for surgical management of his coronary artery disease and mitral regurgitation.
Past Medical History: MR, CAD, BPH, Hyperlipidemia, HTN, SVT vs. NSVT preoperatively, History of severe nose bleeds, Lipoma, s/p Appendectomy, s/p Tonsillectomy, s/p Umbilical Hernia repair  Social History: Retired.
NEURO: Nonfocal  Pertinent Results: [**2162-3-30**] WBC-10.8 Hct-28.0* INR 1.9 [**2162-3-29**] WBC-12.3* RBC-3.37* Hgb-10.6* Hct-30.4* MCV-90 MCH-31.5 MCHC-34.9 RDW-13.3 Plt Ct-460* [**2162-3-30**] UreaN-18 Creat-1.2 K-5.3* [**2162-3-28**] BLOOD Calcium-8.7 Mg-2.6   Brief Hospital Course: Mr. [**Known lastname 1617**] was admitted to the [**Hospital1 18**] on [**2162-3-22**] for surgical management of his mitral valve and coronary artery disease.
On the day of admission, he was taken to the operating room where a mitral valve replacement, coronary artery bypass grafting and a MAZE procedure were performed.
The operation was uneventful but his operative course was complicated by traumatic foley placement secondary to his BPH.
He required flexibile cystoscopy for placement of foley and was started on a [**Doctor Last Name **] drip for hematuria.
Low dose beta blockade was resumed and diuresis was continued.
All afterload agents were temporarily discontinued including Amiodarone in order to maintain cerebral perfusion and avoid further hypotension.
Warfarin anticoagulation was also initiated.
Amiodarone and low dose betablockade were eventually resumed.
Warfarin was dosed daily for a goal INR between 2.0 - 2.5.
All surgical wounds were clean, dry and intact.
Medications on Admission: Amiodarone 400mg Qd Lopressor 25mg [**Hospital1 **] Aspirin 325mg QD HCTZ 25mg QD Fosinopril 40mg QD Serax 15mg QHS Fish oil Calcium Vitamins  Discharge Medications: 1.
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Furosemide 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 10 days.
Tamsulosin 0.4 mg Capsule, Sust.
Amiodarone 200 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Warfarin 2.5 mg Tablet Sig: One (1) Tablet PO QPM: Take as directed by MD.
Senna Laxative 25 mg Tablet Sig: One (1) Tablet PO twice a day.
Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO every 6-8 hours as needed for pain.
Toprol XL 25 mg Tablet Sustained Release 24HR Sig: One (1) Tablet Sustained Release 24HR PO once a day.
Disp:*30 Tablet Sustained Release 24HR(s)* Refills:*2*   Discharge Disposition: Home With Service  Facility: [**Location (un) 932**] VNA  Discharge Diagnosis: MR, CAD, Postop Atrial Fibrillation/SVT, Postop TIA, Hematuria, BPH, Hyperlipidemia, HTN, SVT vs. NSVT preoperatively, History of severe nose bleeds, Lipoma   Discharge Condition: Good   Discharge Instructions: 1) Monitor wounds for signs of infection.
These include redness, drainage or increased pain.
5) No lotions, creams or powders to wound until it has healed.
8) Take Warfarin as directed.
Follow-up with Dr. [**Last Name (STitle) 8521**] for coumadin dosing.
